Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of New Magnetic Resonance Imaging Methods of the Brain
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), February 2008
First Received: February 18, 2000   Last Updated: July 18, 2008   History of Changes
Sponsored by: National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00004577
  Purpose

The purpose of this investigation is to develop improved magnetic resonance imaging (MRI) techniques and hardware for studying brain function. MRI is a diagnostic tool that provides information about brain chemistry and physiology. This study will evaluate new MRI methods for monitoring blood flow to regions of the brain in response to simple tasks. The MRI machine used in this study is more powerful than those in most hospitals, permitting a higher visual resolution.

Normal healthy volunteers over 18 years old may be eligible for this study. Candidates will be screened with a medical history and questionnaire, and a neurological examination. Study participants will have a yearly MRI scan. For this procedure, the subject lies on a stretcher that is moved into a donut-shaped machine with a strong magnetic field. A lightweight circular or rectangular coil-a device that improves the quality of the images-may be placed on the head. The scan time varies from 20 minutes to 3 hours; most scans last between 45 and 90 minutes. During the scan, the subject may perform simple tasks, such as listening to tapes, tapping a finger, moving a hand, watching a screen, or smelling a fragrance. More complex tasks may require thinking about tones or pictures and responding to them by pressing buttons.

Information from this study will be used to develop better imaging methods that will, in turn, permit a greater understanding of normal and abnormal brain behaviors.


Condition
Healthy

Genetics Home Reference related topics: ataxia-telangiectasia
MedlinePlus related topics: MRI Scans Nuclear Scans
U.S. FDA Resources
Study Type: Observational
Official Title: Characterization of Brain Activation at 1.5 and 3.0 Tesla Using Perfusion Images and Blood Oxygen Level Dependent Images

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 340
Study Start Date: February 2000
Detailed Description:

The goal of this protocol is to improve the spatial resolution in MRI studies of the changes in hemodynamics that occur in the central nervous system (CNS) in healthy controls in response to sensory, motor, or cognitive stimulation.

CNS functional changes will be characterized by measuring blood flow, blood transit time, and blood oxygenation. These studies are required in order to develop and implement new imaging techniques for research and clinical applications. The NIMH/NINDS recently acquired a 3.0 T whole body magnetic resonance (MR) unit, located in the In Vivo NMR Research Center. This complements the already existing 1.5 T MR units.

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria
  • INCLUSION CRITERIA:

Any neurologically and psychiatrically normal, male or female, healthy volunteer over 18 years old. Subjects must be capable of understanding the procedures and requirements of this study. Subjects must be willing to sign an informed consent document.

EXCLUSION CRITERIA:

A subject will be excluded if he/she has a contraindication to MR scanning such as the following: pregnancy, aneurysm clip; implanted neural stimulator; implanted cardiac pacemaker or auto-defibrillator; cochlear implant; ocular foreign body (e.g. metal shavings or insulin pump) and any pre-existing eye conditions. Subjects who underwent brain surgery, who have a neurological lesion, a psychiatric history or a history of migraine will also be excluded from this study. The contraindications to MRI at 1.5 T and 3.0 T are identical.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004577

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

Additional Information:
Publications:
Study ID Numbers: 000082, 00-N-0082
Study First Received: February 18, 2000
Last Updated: July 18, 2008
ClinicalTrials.gov Identifier: NCT00004577     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
BOLD Effect
Cerebral Blood Flow
Cerebral Blood Volume
Functional Imaging
Magnetic Resonance Imaging
Technical Developments

Study placed in the following topic categories:
Ataxia-Telangiectasia
Healthy
Ataxia Telangiectasia

ClinicalTrials.gov processed this record on May 07, 2009